Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Classes and Categories01:25

Drug Classes and Categories

2.2K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

437
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
437
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

370
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
370
Analgesia and Pain Management01:25

Analgesia and Pain Management

809
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
809
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Availability of Telehealth Services for Children at Mental Health Treatment Facilities.

JAMA network open·2026
Same author

The Science of Gun Policy: A Critical Synthesis of Research Evidence on the Effects of Gun Policies in the United States, Fifth Edition.

Rand health quarterly·2026
Same author

Medicaid Prior Authorization and Discontinuation of Buprenorphine.

Journal of addiction medicine·2026
Same author

Generics in Medicaid increased in price and shifted to larger manufacturers amid 2022-2023 amphetamine shortage.

Health affairs scholar·2026
Same author

A taxonomy of states' approaches to plans of safe care.

Child abuse & neglect·2026
Same author

AI Chatbot Use and Disclosure for Mental Health Among US Adolescents and Young Adults.

JAMA pediatrics·2026

Related Experiment Video

Updated: Sep 14, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Creating a Classification System of Opioid Use Disorder Treatment Policies: A Research Protocol.

Sean Grant1,2, Rosanna Smart1, Bradley D Stein3

  • 1RAND Corporation, Santa Monica, CA, USA.

Substance Use & Addiction Journal
|July 21, 2025
PubMed
Summary

Developing a standardized classification system for opioid use disorder (OUD) treatment policies is essential for evaluating their effectiveness. This system will improve research, identify policy gaps, and inform public health decisions to combat the overdose crisis.

Keywords:
opioidspolicysubstance use disordertaxonomy

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.3K

Related Experiment Videos

Last Updated: Sep 14, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.3K

Area of Science:

  • Public Health
  • Health Policy Research
  • Addiction Science

Background:

  • The opioid overdose crisis is a major public health concern in the US.
  • Equitable access to effective opioid use disorder (OUD) treatments is a key mitigation strategy.
  • Assessing OUD treatment policy effectiveness is hindered by inconsistent policy definitions and categorization.

Purpose of the Study:

  • To develop an evidence- and consensus-based classification system for OUD treatment policies.
  • To standardize the categorization of OUD treatment policies to improve research and evaluation.
  • To facilitate systematic assessments of existing research and inform policy decisions.

Main Methods:

  • Review existing policy classification systems to create a synthesized list of labels and definitions.
  • Refine the list by examining policy labels and definitions in empirical studies.
  • Conduct expert feedback, reliability testing, and a sorting task for final categorization.

Main Results:

  • A 5-step process was employed to develop a unified classification system for OUD treatment policies.
  • The system aims to enhance clarity, uniqueness, and completeness in policy categorization.
  • Reliability testing will ensure consistent application across different policy areas.

Conclusions:

  • A unified OUD treatment policy classification system will enable comprehensive research assessments.
  • This system can identify policy gaps, guide data collection, and improve future scientific evaluations.
  • Informed policy decisions regarding high-value treatments for specific populations and contexts will be facilitated.